Bayer Announces Availability of
Selected Abstract
Bayer Announces Availability of Reformulated Liquid Leukine(R).
- EDTA removed from product - WAYNE, N.J., May 19 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc. announced today that a reformulation of the liquid Leukine(R) (sargramostim) 500 mcg vial has been approved by the United States Food and Drug Administration (FDA) and is now available for ... May 19, 2008; PR Newswire
Read the full article with a free-trial membership at HighBeam Research
Related Articles 1.
Bayer Announces Availability of Reformulated Liquid Leukine(R).
|
